NDC Code(s) : 0338-3508-41, 0338-3503-41
Packager : Baxter Healthcare Corporation

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

CefazolinCefazolin Sodium INJECTION, SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0338-3508
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CEFAZOLIN SODIUM(UNII: P380M0454Z)
(CEFAZOLIN - UNII:IHS69L0Y4T)
CEFAZOLIN2 g in 100 mL
Inactive Ingredients
Ingredient Name Strength
ANHYDROUS DEXTROSE(UNII: 5SL0G7R0OK)4 g in 100 mL
SODIUM BICARBONATE(UNII: 8MDF5V39QO)
WATER(UNII: 059QF0KO0R)
HYDROCHLORIC ACID(UNII: QTT17582CB)
SODIUM HYDROXIDE(UNII: 55X04QC32I)
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0338-3508-4112 in 1 CASE 08/07/2015
1100 mL in 1 BAG Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA207131 08/07/2015
CefazolinCefazolin Sodium INJECTION, SOLUTION
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0338-3503
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CEFAZOLIN SODIUM(UNII: P380M0454Z)
(CEFAZOLIN - UNII:IHS69L0Y4T)
CEFAZOLIN1 g in 50 mL
Inactive Ingredients
Ingredient Name Strength
ANHYDROUS DEXTROSE(UNII: 5SL0G7R0OK)2 g in 50 mL
SODIUM BICARBONATE(UNII: 8MDF5V39QO)
WATER(UNII: 059QF0KO0R)
HYDROCHLORIC ACID(UNII: QTT17582CB)
SODIUM HYDROXIDE(UNII: 55X04QC32I)
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0338-3503-4124 in 1 CASE 08/07/2015
150 mL in 1 BAG Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA207131 08/07/2015

LABELER - Baxter Healthcare Corporation(005083209)

Establishment
Name Address ID/FEI Business Operations
Baxter Healthcare Corporation 194684502 ANALYSIS(0338-3508, 0338-3503), LABEL(0338-3508, 0338-3503), MANUFACTURE(0338-3508, 0338-3503), PACK(0338-3508, 0338-3503), STERILIZE(0338-3508, 0338-3503)

PRINCIPAL DISPLAY PANEL

Representative Cefazolin Container Label 0338-3503-41 1 of 2Representative Cefazolin Container Label 0338-3503-41 1 of 2Container Label

Cefazolin in Dextrose
Injection, USP
1 g / 50 mL
(20 mg / mL)

GALAXY
Single Dose Container
Discard unused portion

NDC 0338-3503-41
Code 2G3503
Sterile Nonpyrogenic
Iso-osmotic

Each 50 mL contains: 1 g Cefazolin, USP, equivalent to 1.05 g Cefazolin
Sodium, USP with approx. 2 g Dextrose Hydrous, USP added to adjust
osmolality, and Water for Injection, USP. pH may have been adjusted with
sodium bicarbonate or sodium hydroxide/hydrochloric acid.

Dosage: For Intravenous Infusion Only. See prescribing information.
Cautions: Do not add supplementary medication or additives.

Rx only

Store at or below -20°C (-4°F). Thaw at room temperature 20°C to 25°C (68°F to
77°F) or under refrigeration 2°C to 8°C (36°F to 46°F). DO NOT FORCE
THAW BY IMMERSION IN WATER BATHS OR BY MICROWAVE IRRADIATION.
Thawed solution is stable for 30 days under refrigeration or 48 hours at room
temperature. Do not refreeze.

Baxter Logo

Baxter and Galaxy are registered trademarks of
Baxter International Inc.
Manufactured by Baxter Healthcare Corporation
Deerfield, IL 60015 USA
Made in US

PL2040 Plastic

07-34-00-1642

* BAR CODE POSITION
ONLY

303383503411

Representative Cefazolin Container Label 0338-3503-41 1 of 2Representative Cefazolin Container Label 0338-3503-41 1 of 2Carton Label

Thaw at room temperature 20°C to 25°C (68°F to 77°F) or under refrigeration 2°C to 8°C (36°F to 41°F).
DO NOT FORCE THAW BY IMMERSION IN WATER BATHS OR BY MICROWAVE IRRADIATION. Thawed solution is stable for 30 days under refrigeration or 48 hours at room temperature.
Do not refreeze.
Handle frozen product containers with care. Product containers may be fragile in the
frozen state.
Baxter and Galaxy are registered trademarks of Baxter International Inc.
PL 2040 Plastic

07-04-00-0801

Cefazolin in Dextrose Injection, USP
1 g / 50 mL
(20 mg / mL)
Contains 12 units of Single Dose bags. Each bag contains 50 mL Iso-osmotic
Store at or below -20°C (-4°F). Do not refreeze.

Rx Only

NDC 0338-3503-41
Code 2G3503

*FOR BAR CODE POSITION ONLY
(01) 20303383503415

GALAXY Container
Sterile Nonpyrogenic
Each 50 mL contains: 1g Cefazolin, USP, equivalent to 1.05 g Cefazolin Sodium, USP with approx. 2 g
Dextrose Hydrous, USP added to adjust osmolality, and Water for Injection, USP. pH may have been adjusted
with sodium bicarbonate or sodium hydroxide/hydrochloric acid.

Dosage: For Intravenous Infusion Only. See prescribing information.

Cautions: Do not add supplementary medications or additives.

Baxter Logo

Baxter and Galaxy are registered trademarks of Baxter International, Inc.
Baxter Healthcare Corporation
Deerfield, IL 60015 USA

Representative Cefazolin Container Label 0338-3503-41 1 of 2Representative Cefazolin Container Label 0338-3503-41 1 of 2Container Label

Cefazolin in Dextrose
Injection, USP
2 g / 100 mL
(20 mg / mL)

GALAXY
Single Dose Container
Discard unused portion

NDC 0338-3508-41
Code 2G3508
Sterile Nonpyrogenic
Iso-osmotic

Each 100 mL contains: 2 g Cefazolin, USP, equivalent to 2.1 g Cefazolin
Sodium, USP with approx. 4 g Dextrose Hydrous, USP added to adjust
osmolality, and Water for Injection, USP. pH may have been adjusted with
sodium bicarbonate or sodium hydroxide/hydrochloric acid.

Dosage: For Intravenous Infusion Only. See prescribing information.
Cautions: Do not add supplementary medication or additives.

Rx only

Store at or below -20°C (-4°F). Thaw at room temperature 20°C to 25°C (68°F to
77°F) or under refrigeration 2°C to 8°C (36°F to 46°F). DO NOT FORCE THAW
BY IMMERSION IN WATER BATHS OR BY MICROWAVE IRRADIATION.
Thawed
solution is stable for 30 days under refrigeration or 48 hours at room
temperature. Do not refreeze.

Baxter Logo

Baxter and Galaxy are registered trademarks of Baxter International Inc.
Manufactured by Baxter Healthcare Corporation Deerfield, IL 60015 USA
Made in USA

PL2040 Plastic

07-34-00-1643

* BAR CODE POSITION
ONLY

303383508416

Representative Cefazolin Container Label 0338-3503-41 1 of 2Representative Cefazolin Container Label 0338-3503-41 1 of 2Carton Label

Thaw at room temperature 20°C to 25°C (68°F to 77°F) or under refrigeration 2°C to 8°C (36 °F to 41°F).
DO NOT FORCE THAW BY IMMERSION IN WATER BATHS OR BY MICROWAVE IRRADIATION. Thawed solution is stable for 30 days under refrigeration or 48 hours at room temperature.
Do not refreeze.
Handle frozen product containers with care. Product containers may be fragile in the
frozen state.
PL 2040 Plastic
07-04-00-0802

Cefazolin in Dextrose Injection, USP
2 g / 100 mL
(20 mg/ mL)
Contains 6 units of Single Dose bags. Each bag contains 100 mL. Iso-osmotic
Store at or below -20°C (4°F). Do not refreeze.
Lot XXXXXX Exp. DD MMM YY

Rx Only

NDC 0338-3508-41
Code 2G3508

*FOR BAR CODE POSITION ONLY
(01) 20303383508410

GALAXY Container
Sterile Nonpyrogenic
Each 100 mL contains: 2 g Cefazolin, USP, equivalent to 2.1 g Cefazolin Sodium, USP with approx. 4 g
Dextrose Hydrous, USP added to adjust osmolality, and Water for Injection, USP. pH may have been
adjusted with sodium bicarbonate or sodium hydroxide/hydrochloric acid.

Dosage: For Intravenous Infusion Only. See prescribing information.
Cautions: Do not add supplementary medications or additives.

Baxter Logo

Baxter and Galaxy are registered trademarks of Baxter International, Inc.
Baxter Healthcare Corporation
Deerfield, IL 60015 USA